Onychomycosis by common non-dermatophyte moulds;Onicomicosis por hongos ambientales no dermatofíticos

Revista Iberoamericana de Micologia

Volumn 20, Issue 1, 2003, Pages 6-10

  Escobar, Martha Lucía ^a   Carmona Fonseca, Jaime ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Epidemiological profiles; Fusarium; Natrassia; Non dermatophytic fungi; Onychomycosis

Indexed keywords

ACREMONIUM; ARTICLE; ASPERGILLUS; DENDROPHOMA; FEMALE; FUNGUS; FUNGUS CULTURE; FUSARIUM; HUMAN; HYPERHIDROSIS; INOCULATION; MAJOR CLINICAL STUDY; MALE; MOULD; NAIL DYSTROPHY; NATTRASSIA; NONHUMAN; ONYCHOMYCOSIS; PENICILLIUM; SCOPULARIOPSIS BREVICAULIS; SPORT; TRAINING;

ADULT; ASCOMYCOTA; COLOMBIA; FEMALE; FUNGI; FUSARIUM; HUMANS; HYPERHIDROSIS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; MITOSPORIC FUNGI; NAILS; ONYCHOMYCOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SHOES; SPORTS;

ASPERGILLUS; DINEMASPORIUM; FUNGI; FUSARIUM; PENICILLIUM; SCOPULARIOPSIS; SCOPULARIOPSIS BREVICAULIS;

EID: 0038715781     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Joish VN, Armstrong EP. Which antifungal agent for onychomycosis? Pharmacoeconomics 2001; 19: 983-1002.
2. Escobar ML, Carmona J. Examen directo y cultivo en onicomicosis. Piel 2001; 16: 63-68.
3. Zuluaga AI, Tabares AM, Arango M, Robledo MA, Restrepo A, Lotero MC. Importancia creciente de los géneros Fusarium y Scytalidium como agentes de onicomicosis. Dermatología y Cirugía Dermatológica 2001; 9: 593-599.
4. Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clin Microbiol Rev 1997; 11: 415-429.
5. Shaw JW, Joish VN, Conos SJ. Onychomycosis: Health related quality of life considerations. Pharmacoeconomics 2002; 20: 23-36.
6. Sher RK. Diseases of the nails. En: Conn H (Ed.) Current Therapy. Philadelphia: WB. Saunders Co, 1990: 736-742.
7. Virgili A, Zampino MR, Mantovani L. Fungal skin in organ transplant recipients. Am Clin Dermatol. 2002; 3: 19-35.
8. Arrese JE, Pierard FC, Pierard GE. Fatal hyphomycosis following Fusarium onychomycosis in an inmunocompromised patient. Am J Dermatopathol 1996; 18: 196-198.
9. Game MA, Owen WC, Mitchell DK. Cutaneas manifestations of disseminated fungal infection in an inmunocompromissed child. J Pediatric 1998; 133: 466-468.
10. Zaias N, Glick KB, Rebell G. Diagnosing and treating onychomycosis. J Farm Pract 1996; 42: 513-518.
11. Clarif MA, Elewski BE. A historical perspective on onychomycosis. Dermatol Ther 1997; 3: 43-45.
12. Debruyne D, Coquerel A. Pharmacokinetics of antifungal agent in onychomycosis. Clinl Pharmacokinet 2001; 40: 441-472.
13. Mejía MC. Tratamientos de las onicomicosis. En: Carmona-Fonseca J (Ed.) Tópicos de Infectología. Medellín, Universidad de Antioquia, 1997: 135-143.
14. Restrepo A, Arango M, Vélez H, Santamaria L. The isolation of Botryodiplodia theobromae from a nail lesion. Sabouradia 1976; 14: 1-4.
15. Santamaría L, Vélez H, Guzmán G. Dermatomicosis. Análisis retrospectivo de 2336 pacientes; 1976-1980. Acta Médica Colombiana 1982; 7: 453-459.
16. Vélez H, Díaz F. Onychomycosis due to saprophytic fungi. Report of 25 cases. Mycopathologia 1985; 91: 87-92.
17. Vélez H. Onicomicosis por hongos saprofiticos. Informe de 49 casos. latreia 1988; 1: 91-97.
18. Escobar ML, Santamaría L, Díaz F. Dermatomicosis de etiología mixta y por mohos ambientales. Biomédica 1985; 5: 74-77.
19. Escobar ML, Carmona J. Lesiones ungueales y cutáneas por Scytalidium dimidiatum en Medellin (Colombia), 1990-1999. Presentación de 128 casos y revisión del problema del nombre del agente. Iatreia 2000; 13: 140-150.
20. Escobar ML, Carmona J, Santamaria L. Onicomicosis por Malassezia. Rev Iberoam Micol 1999; 16: 225-229.
21. Larone DH. Medicaly important fungi. A guide to identification. 3 ed. Washington DC, ASM Press, 1995.
22. Kwong-Chung K, Bennett JE. Medical Mycology. Philadelphia, Lea and Febiger, 1992.
23. Odds FC. Candida and candidosis. A review and bibliography. 2 ed. London: Bailliere Tindall, 1988.
24. Kane J. In laboratory handbook of dermatophytes. Belmont, Star Publishing Company, 1997.
25. Guého E, Improvisi L, Hoog de GS, Dupont B. Trichosporon on humans: a practical account. Mycoses 1994; 37: 3-10.
26. Centers for Diseases Control and Prevention (CDC-WHO 1986), World Health Organization (Geneve). Epilnfo 6.04. Versión en español. Noviembre 1996.
27. Haneke E. Fungal infections of the nail. Semin Dermatol 1991; 10: 41-53.
28. Zaias N, Oertel L, Elliot DF. Fungi in toe-nails. J Invest Dermatol 1969; 53: 140-142.
29. McAleer R. Fungal infections in the nails in Western Australia. Mycopathologia 1981; 73: 115-120.
30. Greer DL. Envolving role of nondermatophytes in onychomycosis. Int J Dermatol 1995; 34: 521-524.
31. Medvedeva EA, Teregubra GA, Zileeva SA. The dynamics of dermatomycetes in the Bashkir ASSR in 1979-87. Vestn Dermatol Venereol 1990; 2: 58-60.
32. Summerbell RC. Epidemiology and ecology of onychomycosis. Dermatology 1997; 194 (Suppl 1): 32-36.
33. Lym JT, Chua HC, Goh CL. Dermatophyte and non-dermatophyte onychomycosis in Singapore. Australas J Dermatol 1992; 33: 159-163.
34. Clayton YM, Hay RJ. Epidemiology of fungal skin and nail diseases: roundtable discussion held at Dermatology 2000, Vienna, 17 may 1993. Br J Dermatol 1994; 130: 9-11.
35. Mercantini R, Marsella R, Moretto D. Onychomycosis in Roma (Italy). Mycopathologia 1996; 136: 25-32.
36. Ramani R, Srinivas CR, Ramani A, Kumari TG, Shivananda PG. Molds in onychomycosis. Int J Dermatol 1993; 32: 877-878.
37. Roabert N. Champignons non dermatophytes et keratiné ungueale. Etudeexperimentale "in vitro". Arch Belg Dermatol Syph. 1970; 26: 13-20.
38. Oyeka CA, Gugnani HC. Keratin degradation by Scytalidium species and Fusarium solani. Mycoses 1998; 41: 73-76
39. Migdley G, Moore MK. Onychomycosis. Rev Iberoam Micol 1998; 15: 113-117.